A 3D illustration of human lungs. This story was originally published on BioPharma Dive. To receive daily news and insights, subscribe to our free daily BioPharma Dive newsletter. The Food and Drug ...
The COVID-19 pandemic engulfed the U.S. five years ago this month, leaving not only lingering mental health effects but also long-term physical symptoms. One of those included a condition known as ...
Researchers discover that COVID-19 uniquely causes brain inflammation and disrupts serotonin/dopamine pathways, explaining ...
COVID has always been more than a bad bout of flu. As the pandemic’s acute waves recede, a different crisis is coming into focus: a generation of survivors living with damaged lungs, disrupted ...
At first glance, some people seem to have recovered from COVID-19. They no longer test positive and can return to work or school. But for many, the virus leaves behind a lasting impact—especially in ...
AUSTIN, Texas, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Rein Therapeutics (RNTX), a biopharmaceutical company advancing a novel pipeline of first-in-class medicines to address significant unmet medical needs ...
Researchers at the University of Calgary studying a lethal lung disease called pulmonary fibrosis have found that neurons known to help detect pain are also critical for reducing harmful lung ...
Researchers at Tulane University have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people ...
When breathing becomes increasingly difficult with no clear explanation, idiopathic pulmonary fibrosis (IPF) might be the culprit behind the concerning symptoms. This rare yet devastating lung disease ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results